Literature DB >> 19558009

Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxis.

Mutasem Rawas-Qalaji1, F Estelle R Simons, David Collins, Keith J Simons.   

Abstract

BACKGROUND: When epinephrine autoinjectors are unavailable or unaffordable, patients at risk for anaphylaxis in the community are sometimes provided with an unsealed syringe containing a premeasured epinephrine dose for use in first-aid treatment of anaphylaxis episodes.
OBJECTIVES: To study the stability of epinephrine solution in unsealed syringes under conditions of high ambient temperature, low vs high humidity, and light vs dark.
METHODS: Forty unsealed syringes each containing an epinephrine dose of 0.3 mg (as a 1-mg/mL epinephrine solution) were stored at 38 degrees C for 5 months, with 10 syringes at each of 4 different standardized storage conditions: dark and light at low (15%) humidity and dark and light at high (95%) humidity. Duplicate syringes were removed monthly from each storage environment and analyzed for epinephrine content vs control syringes.
RESULTS: The epinephrine dose, expressed as the percentage remaining of the mean control dose, was below compendial limits (90% to 115% of label claim) by 3 months after storage at 38 degrees C and low humidity and by 4 months after storage at 38 degrees C and high humidity. Light had no significant effect.
CONCLUSION: In hot climates, if an unsealed syringe prefilled with an epinephrine dose is provided for the first-aid treatment of anaphylaxis, it should be replaced every few months on a regular basis with a new syringe containing a fresh dose of epinephrine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19558009     DOI: 10.1016/S1081-1206(10)60124-X

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  8 in total

1.  Dissolution testing of sublingual tablets: a novel in vitro method.

Authors:  Ousama Rachid; Mutasem Rawas-Qalaji; F Estelle R Simons; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2011-04-27       Impact factor: 3.246

2.  World allergy organization guidelines for the assessment and management of anaphylaxis.

Authors:  F Estelle R Simons; Ledit R F Ardusso; M Beatrice Bilò; Yehia M El-Gamal; Dennis K Ledford; Johannes Ring; Mario Sanchez-Borges; Gian Enrico Senna; Aziz Sheikh; Bernard Y Thong
Journal:  World Allergy Organ J       Date:  2011-02-23       Impact factor: 4.084

3.  Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use.

Authors:  Ousama Rachid; Mutasem Rawas-Qalaji; Keith J Simons
Journal:  Pharmaceutics       Date:  2018-02-11       Impact factor: 6.321

Review 4.  Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities.

Authors:  Benjamin T Prince; Irene Mikhail; David R Stukus
Journal:  J Asthma Allergy       Date:  2018-06-20

Review 5.  Economic considerations in the treatment of systemic allergic reactions.

Authors:  Emma Westermann-Clark; Amber N Pepper; Richard F Lockey
Journal:  J Asthma Allergy       Date:  2018-06-20

6.  A systematic review of epinephrine stability and sterility with storage in a syringe.

Authors:  Hannah G Parish; Jacquelyn R Morton; Julie C Brown
Journal:  Allergy Asthma Clin Immunol       Date:  2019-02-21       Impact factor: 3.406

7.  Anaphylaxis diagnosis and management in the Emergency Department of a tertiary hospital in the Philippines.

Authors:  Michelle Joy De Vera; Iris Conela Tagaro
Journal:  Asia Pac Allergy       Date:  2020-01-13

Review 8.  Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.

Authors:  Aziz Sheikh; F Estelle R Simons; Victoria Barbour; Allison Worth
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.